Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Jason A Mouabbi"'
Autor:
Harriet T Rothschild, A Jo Chien, Rachel C Jankowitz, Mark JM Magbanua, Jason A Mouabbi, Rebecca A Shatsky, Julia Levine, Rita A Mukhtar
Publikováno v:
Journal of Clinical and Translational Science, Vol 7 (2023)
Externí odkaz:
https://doaj.org/article/dec56e74e570449e8b7a13ba78b77b8b
Autor:
Jason A. Mouabbi, Akshara Singareeka Raghavendra, Roland L. Bassett, Amy Hassan, Debu Tripathy, Rachel M. Layman
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract The addition of targeted therapies (TT) to endocrine therapy (ET) has improved the outcomes of patients with HR-positive, HER2-negative metastatic breast cancer (mBC). However, it is unknown whether patients with invasive lobular carcinoma (
Externí odkaz:
https://doaj.org/article/982f3e9cb56b48ee9ecd4add8542b9a0
Autor:
Jason A. Mouabbi, Momal Chand, Ishaq A. Asghar, Ramen Sakhi, Daniel Ockner, Carrie L. Dul, Tarik Hadid, Amr Aref, Mothaffar F. Rimawi, Valentina Hoyos
Publikováno v:
Cancer Medicine, Vol 10, Iss 14, Pp 4790-4795 (2021)
Abstract Objective The goal was to compare the 5‐year DFS and 5‐year OS in patients with early‐stage human epidermal growth factor receptor 2 breast cancer (HER2+ BC) and triple‐negative breast cancer (TNBC) in relation to the amount of strom
Externí odkaz:
https://doaj.org/article/c6a62fe8c1c74ba0a71fb27937d91dca
Autor:
Jason A. Mouabbi, Amy Hassan, Bora Lim, Gabriel N. Hortobagyi, Debasish Tripathy, Rachel M. Layman
Publikováno v:
Breast Cancer Research and Treatment. 193:253-264
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d50af961a93692ae3f2c0856aa6077c9
https://doi.org/10.1007/s10549-022-06572-w
https://doi.org/10.1007/s10549-022-06572-w
Publikováno v:
Breast Cancer Research and Treatment. 190:189-201
Estrogen receptor (ER) is the major driver of most metastatic breast cancers (mBCs). Endocrine therapy (ET) is the most effective treatment for ER + mBC, but its effectiveness is limited by high rates of de novo and acquired resistance. A growing und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18a12dc939ea3aa8749869c97ed47f92
https://doi.org/10.1007/s10549-021-06383-5
https://doi.org/10.1007/s10549-021-06383-5
Autor:
Momal Chand, Valentina Hoyos, Jason A Mouabbi, Daniel Ockner, Mothaffar F. Rimawi, Amr Aref, Tarik Hadid, Ramen Sakhi, Carrie L. Dul, Ishaq A. Asghar
Publikováno v:
Cancer Medicine, Vol 10, Iss 14, Pp 4790-4795 (2021)
Cancer Medicine
Cancer Medicine
Objective The goal was to compare the 5‐year DFS and 5‐year OS in patients with early‐stage human epidermal growth factor receptor 2 breast cancer (HER2+ BC) and triple‐negative breast cancer (TNBC) in relation to the amount of stromal tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b43451735322b9542c100cf189a4da92
https://doaj.org/article/c6a62fe8c1c74ba0a71fb27937d91dca
https://doaj.org/article/c6a62fe8c1c74ba0a71fb27937d91dca
Autor:
Jason A. Mouabbi, Akshara Singareeka Raghavendra, Roland L. Bassett, Amy Hassan, Debasish Tripathy, Rachel M. Layman
Publikováno v:
JAMA Network Open. 6:e2313017
ImportanceApproximately 45% to 60% of hormone receptor (HR)–positive metastatic breast cancer (mBC) shows a low-level expression of ERBB2. Low ERBB2 expression is defined as ERBB2 immunohistochemical expression of 1+ or 2+ with a negative ERBB2 amp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1bb999bec0099be4d878e3076a759cf
https://doi.org/10.1001/jamanetworkopen.2023.13017
https://doi.org/10.1001/jamanetworkopen.2023.13017
Publikováno v:
Cancer Research. 81:PS3-30
Background: Accurate determination of the extent of tumor is essential when a breast-conserving therapy (BCT) is considered. Due to its high sensitivity, breast magnetic resonance imaging (MRI) is increasingly used for the accurate diagnosis and surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ace34e1b26925760e81c4cfee67bea3
https://doi.org/10.1158/1538-7445.sabcs20-ps3-30
https://doi.org/10.1158/1538-7445.sabcs20-ps3-30
Autor:
Rohit Kumar, Tarik Hadid, Sindhu Janarthanam Malapati, Sunny Rk Singh, Jason A Mouabbi, Ahmed Abdalla, Carrie L. Dul
Publikováno v:
Cancer Research. 80:P2-08
Background: The utilization of bilateral (B/L) mastectomy for ductal carcinoma in situ (DCIS) has been rising within the last two decades. This is occurring despite the lack of convincing evidence to support the positive impact of this approach on di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7130ebe6c8bd941ef132b68fc130df4d
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-04
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-04
Autor:
Ramen Sakhi, Amr Aref, Daniel Ockner, Jason A Mouabbi, Carrie L. Dul, Zyad Kafri, Tarik Hadid, Susan Szpunar, Momal Chand
Publikováno v:
Cancer Research. 80:P4-12
Background: There is a strong evidence indicating that locoregional control of early-stage breast cancer either by lumpectomy with radiation therapy or by mastectomy yields similar rates of disease-free survival (DFS) and overall survival (OS). Recen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03b5ffe360725c77daa51f0ceb26c9ad
https://doi.org/10.1158/1538-7445.sabcs19-p4-12-09
https://doi.org/10.1158/1538-7445.sabcs19-p4-12-09